CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Trade Cardiff Oncology, Inc. - CRDF CFD

3.4250
1.18%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.0400
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023346 %
Charges from full value of position ($-0.23)
Trade size with leverage ~ $2,000.00
Money from leverage ~ $1,000.00

Go to platform
-0.023346%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001124 %
Charges from full value of position ($0.01)
Trade size with leverage ~ $2,000.00
Money from leverage ~ $1,000.00

Go to platform
0.001124%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 50.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 3.39
Open 3.41
1-Year Change 111.16%
Day's Range 3.365 - 3.485
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jan 17, 2025 3.4250 0.0050 0.15% 3.4200 3.4850 3.3400
Jan 16, 2025 3.3900 -0.0100 -0.29% 3.4000 3.4800 3.3100
Jan 15, 2025 3.4250 0.0850 2.54% 3.3400 3.4850 3.2800
Jan 14, 2025 3.2800 -0.2500 -7.08% 3.5300 3.5500 3.2600
Jan 13, 2025 3.4500 -0.1100 -3.09% 3.5600 3.5600 3.3800
Jan 10, 2025 3.6000 -0.2500 -6.49% 3.8500 3.8600 3.5950
Jan 8, 2025 3.8850 -0.1250 -3.12% 4.0100 4.0900 3.8100
Jan 7, 2025 4.0750 -0.3950 -8.84% 4.4700 4.5100 4.0450
Jan 6, 2025 4.4900 -0.1800 -3.85% 4.6700 4.8400 4.4900
Jan 3, 2025 4.6600 0.4100 9.65% 4.2500 4.6900 4.2100
Jan 2, 2025 4.2400 -0.0900 -2.08% 4.3300 4.6150 4.2100
Dec 31, 2024 4.3000 0.1200 2.87% 4.1800 4.3800 4.1800
Dec 30, 2024 4.2400 0.0100 0.24% 4.2300 4.5000 4.1100
Dec 27, 2024 4.3000 0.0500 1.18% 4.2500 4.4600 4.0400
Dec 26, 2024 4.2900 0.3600 9.16% 3.9300 4.3900 3.9000
Dec 24, 2024 3.8600 -0.1500 -3.74% 4.0100 4.1800 3.7900
Dec 23, 2024 4.0500 -0.2900 -6.68% 4.3400 4.3400 3.9600
Dec 20, 2024 4.2400 -0.0900 -2.08% 4.3300 4.6600 4.1700
Dec 19, 2024 4.4600 -0.3600 -7.47% 4.8200 4.9700 4.4500
Dec 18, 2024 4.4650 -0.7750 -14.79% 5.2400 5.2900 4.3000

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
Leverage
2:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Cardiff Oncology, Inc. Company profile

Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer. Its lead drug candidate is onvansertib, a Polo-like Kinase 1 selective adenosine triphosphate competitive inhibitor that is in Phase Ib/II clinical trial in acute myeloid leukemia (AML); has completed a Phase I clinical trial in advanced solid tumors; and Phase Ib/II clinical trial for metastatic colorectal cancer in combination with FOLFIRI and Avastin. The company''s onvansertib is also in Phase II clinical trial in combination with Zytiga for metastatic castration-resistant prostate cancer. In addition, it develops therapeutics, such as belinostat (Beleodaq); quizartinib (AC220), a development stage FLT3 inhibitor; and bortezomib (Velcade) for the treatment of leukemias, lymphomas, and solid tumor cancers. The company primarily serves pharmaceutical companies. Cardiff Oncology, Inc. has a research collaboration with Nektar Therapeutics for the treatment of colorectal cancer. The company was formerly known as Trovagene, Inc. and changed its name to Cardiff Oncology, Inc. in May 2020. Cardiff Oncology, Inc. was founded in 1999 and is headquartered in San Diego, California.
Industry: Biotechnology & Medical Research (NEC)

11055 Flintkote Ave
SAN DIEGO
CALIFORNIA 92121
US

People also watch

ETH/USD

3,294.27 Price
-5.220% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

Gold

2,703.08 Price
-0.430% 1D Chg, %
Long position overnight fee 0.0056%
Short position overnight fee -0.0138%
Overnight fee time 22:00 (UTC)
Spread 0.60

US100

21,441.70 Price
+1.820% 1D Chg, %
Long position overnight fee -0.0233%
Short position overnight fee 0.0011%
Overnight fee time 22:00 (UTC)
Spread 7.0

BTC/USD

102,841.45 Price
-1.750% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading